Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer

Clinical trial NCT02137252 · TERMINATED

Trial details

NCT number: NCT02137252
Sponsor: Dana-Farber Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Invasive Breast Cancer (Stage I-III)Ductal Carcinoma in Situ Lobular Carcinoma in Situ Lobular Carcinoma Fatigue Related to Cancer Treatment

Start date: 2014-05-01
Primary completion: 2015-08-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.